immunotherapy/gene therapy (Transgene)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameimmunotherapy/gene therapy (Transgene)
Drug Alias Nameretrovirus IFN-beta (Transgene)retrovirus IFN-alpha (Transgene)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransgene Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut National De La Sante Et De La Recherche MedicaleTransgene Sa
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A